Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P920015/S302

HV Splitter/Adaptor kit 5019 IS-1 Connector Port Pin Plug Kit 6725 Sprint Quattro Lead 6935, 6947 Sprint Quattro Lead 69

Medtronic, Inc. · Decision date Feb 10, 2026

FDA DECISIONP920015/S302

What did the FDA decide?

FDA records P920015/S302 as a supplement to PMA P920015, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 10, 2026.

FDA approval order statement

a new vapor degreasing solvent
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Feb 10, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P920015/S302
Regulatory pathway
PMA supplement
Product code
NVY
Decision code
OK30
Decision date
Feb 10, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Permanent defibrillator electrodes.

Product code
NVY
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P920015/S302 received

    Application receipt date recorded by FDA.

  2. P920015/S302 · FDA decision

    30-Day Notice

  3. P920015/S303 · Related supplement

    Sprint Quattro Lead (6935M, 6947); Sprint Quattro Lead (6935, 6947M)

  4. P920015/S304 · Related supplement

    HV Splitter/ Adaptor kit

  5. P920015/S305 · Related supplement

    ACCESS 6717 KIT PIN PLUG (6717), DF-1 Connector Port Pin Plug (6719), IS-1 Connector Port Pin Plug Kit (6725), Sprint Qu

  6. P920015/S306 · Related supplement

    Sprint Quattro Lead (6946M)

  7. P920015/S307 · Related supplement

    MEDTRONIC(R) TRANSVENE LEAD SYSTEM

Timeline entries are records held by MedtechLedger for P920015. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P920015

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementFeb 13, 2026FDA
Medtronic, Inc.PMA supplementMar 6, 2026FDA
Medtronic, Inc.PMA supplementApr 15, 2026FDA
Medtronic, Inc.PMA supplementJun 24, 2026FDA
Medtronic, Inc.PMA supplementAug 19, 2026FDA

Explore the linked device profile

Other records with product code NVY

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic, Inc.PMA supplementOct 23, 2026FDA
Medtronic, Inc.PMA supplementApr 24, 2026FDA
Medtronic, Inc.PMA supplementApr 24, 2026FDA
Medtronic, Inc.PMA supplementMar 9, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St. N.E, Ms Mvs11, Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records